Bank Pictet & Cie (Europe)’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.1M | Buy |
150,642
+33,067
| +28% | +$2.89M | 0.28% | 64 |
|
|
2025
Q1 | $8.03M | Buy |
117,575
+6,512
| +6% | +$445K | 0.19% | 71 |
|
|
2024
Q4 | $8.64M | Buy |
111,063
+2,010
| +2% | +$156K | 0.19% | 66 |
|
|
2024
Q3 | $7.31M | Buy |
109,053
+24,411
| +29% | +$1.64M | 0.17% | 70 |
|
|
2024
Q2 | $9.6M | Buy |
84,642
+12,318
| +17% | +$1.4M | 0.23% | 62 |
|
|
2024
Q1 | $10M | Buy |
72,324
+32,212
| +80% | +$4.47M | 0.26% | 67 |
|
|
2023
Q4 | $4.98M | Sell |
40,112
-3,845
| -9% | -$477K | 0.15% | 82 |
|
|
2023
Q3 | $4.1M | Buy |
43,957
+39,394
| +863% | +$3.68M | 0.14% | 89 |
|
|
2023
Q2 | $586K | Buy |
4,563
+2,210
| +94% | +$284K | 0.02% | 167 |
|
|
2023
Q1 | $273K | Sell |
2,353
-1,641
| -41% | -$191K | 0.01% | 156 |
|
|
2022
Q4 | $452K | Sell |
3,994
-990
| -20% | -$112K | 0.02% | 124 |
|
|
2022
Q3 | $401K | Hold |
4,984
| – | – | 0.02% | 127 |
|
|
2022
Q2 | $371K | Sell |
4,984
-2,380
| -32% | -$177K | 0.02% | 125 |
|
|
2022
Q1 | $942K | Buy |
7,364
+1,528
| +26% | +$195K | 0.04% | 105 |
|
|
2021
Q4 | $783K | Buy |
5,836
+672
| +13% | +$90.2K | 0.03% | 112 |
|
|
2021
Q3 | $706K | Sell |
5,164
-17,828
| -78% | -$2.44M | 0.03% | 115 |
|
|
2021
Q2 | $2.45M | Buy |
22,992
+1,128
| +5% | +$120K | 0.09% | 85 |
|
|
2021
Q1 | $1.96M | Buy |
21,864
+5,976
| +38% | +$537K | 0.08% | 90 |
|
|
2020
Q4 | $1.47M | Buy |
+15,888
| New | +$1.47M | 0.07% | 85 |
|
|
2018
Q2 | – | Sell |
-20,868
| Closed | -$387K | – | 152 |
|
|
2018
Q1 | $387K | Buy |
20,868
+2,348
| +13% | +$43.5K | 0.06% | 129 |
|
|
2017
Q4 | $266K | Buy |
+18,520
| New | +$266K | 0.04% | 151 |
|